Epidemiology of alpha-synucleinopathies: from Parkinson disease to dementia with Lewy bodies

Handbook of Clinical Neurology

Volumn 138, Issue , 2016, Pages 153-158

  Savica, R ^a   Boeve, B F ^a   Logroscino, G ^a,b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

dementia; dementia with Lewy bodies; incidence; Parkinson's disease; prevalence

Indexed keywords

AGE DISTRIBUTION; AGED; FEMALE; HUMAN; INCIDENCE; LEWY BODY DISEASE; MALE; MIDDLE AGED; PARKINSON DISEASE; PREVALENCE; SEX RATIO; VERY ELDERLY;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INCIDENCE; LEWY BODY DISEASE; MALE; MIDDLE AGED; PARKINSON DISEASE; PREVALENCE; SEX DISTRIBUTION;

EID: 84999791281     PISSN: 00729752     EISSN: 22124152     Source Type: Book Series    
DOI: 10.1016/B978-0-12-802973-2.00009-4     Document Type: Chapter

References (43)

1. Abbott, R.D., Ross, G.W., Petrovitch, H., et al. Bowel movement frequency in late-life and incidental Lewy bodies. Mov Disord 22 (2007), 1581–1586.
2. Anonymous, Parkinson's Disease: National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care. 2006 London https://www.nice.org.uk/guidance/cg35/evidence/full-guideline-194930029.
3. Bach, J.P., Ziegler, U., Deuschl, G., et al. Projected numbers of people with movement disorders in the years 2030 and 2050. Mov Disord 26 (2011), 2286–2290.
4. Boot, B.P., Orr, C.F., Ahlskog, J.E., Ferman, T.J., et al. Risk factors for dementia with Lewy bodies: a case-control study. Neurology., 81(9), 2013, 833–840, 10.1212/WNL.0b013e3182a2cbd1 Epub 2013, Jul 26.
5. Bower, J.H., Maraganore, D.M., Mcdonnell, S.K., et al. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990. Neurology 52 (1999), 1214–1220.
6. Bower, J.H., Maraganore, D.M., Mcdonnell, S.K., et al. Influence of strict, intermediate, and broad diagnostic criteria on the age- and sex-specific incidence of Parkinson's disease. Mov Disord 15 (2000), 819–825.
7. Buchman, A.S., Yu, L., Wilson, R.S., et al. Association of brain pathology with the progression of frailty in older adults. Neurology 80 (2013), 2055–2061.
8. Cooper, R., Cutler, J., Desvigne-Nickens, P., et al. Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention. Circulation 102 (2000), 3137–3147.
9. Crystal, H.A., Dickson, D.W., Lizardi, J.E., et al. Antemortem diagnosis of diffuse Lewy body disease. Neurology 40 (1990), 1523–1528.
10. De Lau, L.M., Giesbergen, P.C., De Rijk, M.C., et al. Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study. Neurology 63 (2004), 1240–1244.
11. De Rijk, E.P., Van Strien, F.J., Roubos, E.W., Demonstration of coexisting catecholamine (dopamine), amino acid (GABA), and peptide (NPY) involved in inhibition of melanotrope cell activity in Xenopus laevis: a quantitative ultrastructural, freeze-substitution immunocytochemical study. J Neurosci 12 (1992), 864–871.
12. De Rijk, M.C., Rocca, W.A., Anderson, D.W., et al. A population perspective on diagnostic criteria for Parkinson's disease. Neurology 48 (1997), 1277–1281.
13. De Silva, H.A., Gunatilake, S.B., Smith, A.D., Prevalence of dementia in a semi-urban population in Sri Lanka: report from a regional survey. Int J Geriatr Psychiatry 18 (2003), 711–715.
14. Eller, M., Williams, D.R., alpha-Synuclein in Parkinson disease and other neurodegenerative disorders. Clin Chem Lab Med 49 (2011), 403–408.
15. Erekson, E.A., Fried, T.R., Martin, D.K., et al. Frailty, cognitive impairment, and functional disability in older women with female pelvic floor dysfunction. Int Urogynecol J 26 (2015), 823–830.
16. Fereshtehnejad, S.M., Damangir, S., Cermakova, P., et al. Comorbidity profile in dementia with Lewy bodies versus Alzheimer's disease: a linkage study between the Swedish Dementia Registry and the Swedish National Patient Registry. Alzheimers Res Ther, 6, 2014, 65.
17. Fereshtehnejad, S.M., Romenets, S.R., Anang, J., et al. Clinical subtypes of Parkinson's disease and disease progression: Data-driven comparison of new phenotypes with other cluster solutions [abstract]. Mov Disord, 30(Suppl 1), 2015, 685.
18. Ferman, T.J., Smith, G.E., Boeve, B.F., et al. DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging. Neurology 62 (2004), 181–187.
19. Frigerio, R., Fujishiro, H., Maraganore, D.M., et al. Comparison of risk factor profiles in incidental Lewy body disease and Parkinson disease. Arch Neurol 66 (2009), 1114–1119.
20. Frigerio, R., Fujishiro, H., Ahn, T.B., et al. Incidental Lewy body disease: do some cases represent a preclinical stage of dementia with Lewy bodies?. Neurobiol Aging 32 (2011), 857–863.
21. Galvin, J.E., Duda, J.E., Kaufer, D.I., et al. Lewy body dementia: the caregiver experience of clinical care. Parkinsonism Relat Disord 16 (2010), 388–392.
22. Giancarlo Logroscino, R.T., Imaging IN Neurodegenerative Disorders. 2014, Oxford Press, Oxford.
23. Global Burden of Disease Study Collaborators, Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386 (2015), 743–800.
24. Harding, A.J., Broe, G.A., Halliday, G.M., Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain 125 (2002), 391–403.
25. Last, J.M., International Epidemiological Association, A dictionary of epidemiology. 2001, Oxford University Press, New York.
26. Lee, H.J., Patel, S., Lee, S.J., Intravesicular localization and exocytosis of alpha-synuclein and its aggregates. J Neurosci 25 (2005), 6016–6024.
27. Levy, G., Tang, M.X., Cote, L.J., et al. Motor impairment in PD: relationship to incident dementia and age. Neurology 55 (2000), 539–544.
28. Litvan, I., Macintyre, A., Goetz, C.G., et al. Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. Arch Neurol 55 (1998), 969–978.
29. Luis, C.A., Barker, W.W., Gajaraj, K., et al. Sensitivity and specificity of three clinical criteria for dementia with Lewy bodies in an autopsy-verified sample. Int J Geriatr Psychiatry 14 (1999), 526–533.
30. Manford, M., Andermann, F., Complex visual hallucinations. Clinical and neurobiological insights. Brain 121:Pt 10 (1998), 1819–1840.
31. Mckeith, I., Dementia in Parkinson's disease: common and treatable. Lancet Neurol, 3, 2004, 456.
32. Mckeith, I.G., Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. J Alzheimers Dis 9 (2006), 417–423.
33. Mckeith, I., Mintzer, J., Aarsland, D., et al. Dementia with Lewy bodies. Lancet Neurol 3 (2004), 19–28.
34. Mckeith, I.G., Dickson, D.W., Lowe, J., et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65 (2005), 1863–1872.
35. Miech, R.A., Breitner, J.C., Zandi, P.P., et al. Incidence of AD may decline in the early 90s for men, later for women: The Cache County study. Neurology 58 (2002), 209–218.
36. Pringsheim, T., Jette, N., Frolkis, A., et al. The prevalence of Parkinson's disease: a systematic review and meta-analysis. Mov Disord 29 (2014), 1583–1590.
37. Rahkonen, T., Eloniemi-Sulkava, U., Rissanen, S., et al. Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or older. J Neurol Neurosurg Psychiatry 74 (2003), 720–724.
38. Savica, R., Grossardt, B.R., Bower, J.H., et al. Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism. JAMA Neurol 70 (2013), 859–866.
39. Savica, R., Grossardt, B.R., Bower, J.H., et al. Incidence of dementia with Lewy bodies and Parkinson disease dementia. JAMA Neurol 70 (2013), 1396–1402.
40. Stevens, T., Livingston, G., Kitchen, G., et al. Islington study of dementia subtypes in the community. Br J Psychiatry 180 (2002), 270–276.
41. Twelves, D., Perkins, K.S., Counsell, C., Systematic review of incidence studies of Parkinson's disease. Mov Disord 18 (2003), 19–31.
42. Yamada, T., Hattori, H., Miura, A., et al. Prevalence of Alzheimer's disease, vascular dementia and dementia with Lewy bodies in a Japanese population. Psychiatry Clin Neurosci 55 (2001), 21–25.
43. Yamada, T., Kadekaru, H., Matsumoto, S., et al. Prevalence of dementia in the older Japanese-Brazilian population. Psychiatry Clin Neurosci 56 (2002), 71–75.